http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190017169-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d0fc2b70675ee19bd5fc464f5ae9061 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-203 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-46 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203 |
filingDate | 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ea6ce67667338ebd896bb560fa0ff7 |
publicationDate | 2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20190017169-A |
titleOfInvention | Glycosyl-attached Ospemifene, Method for Preparing Thereof and Pharmaceutical Compositions Containing The Same as Active Ingredients |
abstract | The present invention relates to a novel ospemipene derivative compound to which a sugar is added to ospemifene, which is a selective estrogen receptor modulator (SERM), and a method for producing the compound, The bioavailability is improved compared to pen, and the bioavailability is also improved in comparison with the original compound ospemiphen, which provides the therapeutic effect of diseases such as dyspareunia and vaginal dryness in postmenopausal women , And can be usefully used as an improved formulation. |
priorityDate | 2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 503.